₹2800 crore remains manageable though. But due to the covid-led disruption, deleveraging could be pushed behind. The company might also have to take up some additional borrowing during the next few quarters.Even so, the covid-19 led disruption will result in a challenging year for Apollo Hospitals.
The stock trades at a valuation of 45 times FY20 earnings, even as profitability could take a hit in FY21. Hospital chains that were coming out of the hospitals will take some time to nurse their business back to health given the covid-19 slowdown.Click here to read the Mint ePaperLivemint.com is now on Telegram.